275 related articles for article (PubMed ID: 28855598)
21. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
22. Effect of the English familial disease mutation (H6R) on the monomers and dimers of Aβ40 and Aβ42.
Viet MH; Nguyen PH; Derreumaux P; Li MS
ACS Chem Neurosci; 2014 Aug; 5(8):646-57. PubMed ID: 24949887
[TBL] [Abstract][Full Text] [Related]
23. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides.
Chong SH; Yim J; Ham S
Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498
[TBL] [Abstract][Full Text] [Related]
24. Impact of K16A and K28A mutation on the structure and dynamics of amyloid-β
Shuaib S; Saini RK; Goyal D; Goyal B
J Biomol Struct Dyn; 2020 Feb; 38(3):708-721. PubMed ID: 30821624
[TBL] [Abstract][Full Text] [Related]
25. Interactions of a multifunctional di-triazole derivative with Alzheimer's Aβ
Kaur A; Shuaib S; Goyal D; Goyal B
Phys Chem Chem Phys; 2020 Jan; 22(3):1543-1556. PubMed ID: 31872820
[TBL] [Abstract][Full Text] [Related]
26. Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity.
Diomede L; Di Fede G; Romeo M; Bagnati R; Ghidoni R; Fiordaliso F; Salio M; Rossi A; Catania M; Paterlini A; Benussi L; Bastone A; Stravalaci M; Gobbi M; Tagliavini F; Salmona M
Neurobiol Dis; 2014 Feb; 62():521-32. PubMed ID: 24184799
[TBL] [Abstract][Full Text] [Related]
27. Molecular structure of the NQTrp inhibitor with the Alzheimer Aβ1-28 monomer.
Tarus B; Nguyen PH; Berthoumieu O; Faller P; Doig AJ; Derreumaux P
Eur J Med Chem; 2015 Feb; 91():43-50. PubMed ID: 25011560
[TBL] [Abstract][Full Text] [Related]
28. Pathogenic Aβ A2V versus protective Aβ A2T mutation: Early stage aggregation and membrane interaction.
Colombo L; Gamba A; Cantù L; Salmona M; Tagliavini F; Rondelli V; Del Favero E; Brocca P
Biophys Chem; 2017 Oct; 229():11-18. PubMed ID: 28502484
[TBL] [Abstract][Full Text] [Related]
29. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
Sun Y; Qian Z; Wei G
Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
[TBL] [Abstract][Full Text] [Related]
30. Neurotoxic Effects of Aβ6-42 Peptides Mimicking Putative Products Formed by the Angiotensin Converting Enzyme.
Medvedev AE; Radko SP; Yurinskaya MM; Vinokurov MG; Buneeva OA; Kopylov AT; Kozin SA; Mitkevich VA; Makarov AA
J Alzheimers Dis; 2018; 66(1):263-270. PubMed ID: 30282362
[TBL] [Abstract][Full Text] [Related]
31. Molecular Dynamics Simulations of Amyloid β-Peptide (1-42): Tetramer Formation and Membrane Interactions.
Brown AM; Bevan DR
Biophys J; 2016 Sep; 111(5):937-49. PubMed ID: 27602722
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail.
Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR
ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450
[TBL] [Abstract][Full Text] [Related]
33. Significantly different contact patterns between Aβ40 and Aβ42 monomers involving the N-terminal region.
Liu Z; Jiang F; Wu YD
Chem Biol Drug Des; 2019 Sep; 94(3):1615-1625. PubMed ID: 30381893
[TBL] [Abstract][Full Text] [Related]
34. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
Kim W; Hecht MH
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
[TBL] [Abstract][Full Text] [Related]
35. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
Shuaib S; Goyal B
J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
[TBL] [Abstract][Full Text] [Related]
36. Aβ41 Aggregates More Like Aβ40 than Like Aβ42: In Silico and in Vitro Study.
Nguyen HL; Thi Minh Thu T; Truong PM; Lan PD; Man VH; Nguyen PH; Tu LA; Chen YC; Li MS
J Phys Chem B; 2016 Aug; 120(30):7371-9. PubMed ID: 27388669
[TBL] [Abstract][Full Text] [Related]
37. Evidence of Molecular Interactions of Aβ1-42 with N-Terminal Truncated Beta Amyloids by NMR.
Tomaselli S; Pagano K; D'Arrigo C; Molinari H; Ragona L
ACS Chem Neurosci; 2017 Apr; 8(4):759-765. PubMed ID: 28135060
[TBL] [Abstract][Full Text] [Related]
38. Polymorphic structures of Alzheimer's β-amyloid globulomers.
Yu X; Zheng J
PLoS One; 2011; 6(6):e20575. PubMed ID: 21687730
[TBL] [Abstract][Full Text] [Related]
39. Effect of Alzheimer's Disease Causative and Protective Mutations on the Hydration Environment of Amyloid-β.
Aggarwal L; Biswas P
J Phys Chem B; 2020 Mar; 124(12):2311-2322. PubMed ID: 32130011
[TBL] [Abstract][Full Text] [Related]
40. Effect of Taiwan mutation (D7H) on structures of amyloid-β peptides: replica exchange molecular dynamics study.
Truong PM; Viet MH; Nguyen PH; Hu CK; Li MS
J Phys Chem B; 2014 Jul; 118(30):8972-81. PubMed ID: 25010208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
